Allergic asthma: An indication for allergen immunotherapy.

allergen-specific immunotherapy (AIT) allergic asthma asthma environmental allergens meta-analyses

Journal

Allergologie select
ISSN: 2512-8957
Titre abrégé: Allergol Select
Pays: Germany
ID NLM: 101722686

Informations de publication

Date de publication:
2023
Historique:
received: 16 03 2022
accepted: 16 11 2022
entrez: 17 3 2023
pubmed: 18 3 2023
medline: 18 3 2023
Statut: epublish

Résumé

. Allergen immunotherapy (AIT) as a validated, disease-modifying treatment is nowadays a widely recommended therapy option for allergic rhinitis and allergic asthma. The registration of allergen extracts used for AIT is based on allergen standardization, dose finding trials, and phase 3 trials proving their efficacy in high-quality, statistically significant randomized clinical trials. Real-world evidence (RWE) studies confirm the clinical relevance of these findings. The most data are available for the treatment of patients suffering from allergic rhinitis. Due to the similar inflammatory mechanisms, allergic rhinitis is often associated with allergic asthma. AIT, which induces tolerance against individual allergens, is the approach to treat the underlying mechanisms of these two interrelated respiratory diseases. Some trials have been published focusing primarily on the effect of AIT on parameters of allergic asthma. Here we give a summary of the evidence for the efficacy of AIT in the indication of allergic asthma.

Identifiants

pubmed: 36925993
doi: 10.5414/ALX02332E
pmc: PMC10012881
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

33-38

Informations de copyright

© Dustri-Verlag Dr. K. Feistle.

Références

Allergy. 2019 Mar;74(3):594-604
pubmed: 30183091
Allergy. 2019 May;74(5):855-873
pubmed: 31095767
Lancet Reg Health Eur. 2021 Nov 30;13:100275
pubmed: 34901915
Allergy. 2020 Aug;75(8):2050-2058
pubmed: 32080856
Patient Prefer Adherence. 2020 May 13;14:817-827
pubmed: 32494127
J Asthma Allergy. 2020 Nov 10;13:575-587
pubmed: 33204114
J Allergy Clin Immunol. 2010 Nov;126(5):942-9
pubmed: 20624650
Allergy. 2019 Jul;74(7):1317-1326
pubmed: 30589088
J Allergy Clin Immunol. 2015 Dec;136(6):1511-1516
pubmed: 26371838
Cochrane Database Syst Rev. 2010 Aug 04;(8):CD001186
pubmed: 20687065
Allergy. 2018 Jan;73(1):165-177
pubmed: 28561266
Cochrane Database Syst Rev. 2020 Sep 14;9:CD011293
pubmed: 32926419
Front Pediatr. 2018 Aug 21;6:231
pubmed: 30186823
JAMA. 2016 Apr 26;315(16):1715-25
pubmed: 27115376
J Allergy Clin Immunol. 2021 Mar;147(3):1020-1030.e10
pubmed: 32890575
Curr Opin Allergy Clin Immunol. 2019 Dec;19(6):594-605
pubmed: 31464717
Allergol Select. 2022 Sep 6;6:167-232
pubmed: 36178453
J Allergy Clin Immunol. 2014 Sep;134(3):568-575.e7
pubmed: 24797423
Expert Rev Respir Med. 2020 May;14(5):445-452
pubmed: 32131649
Allergy. 2020 Mar;75(3):596-602
pubmed: 31408535
Allergy. 2006 Feb;61(2):191-7
pubmed: 16409195
Allergy. 2017 Dec;72(12):1825-1848
pubmed: 28543086
J Allergy Clin Immunol. 2022 Mar;149(3):881-883
pubmed: 34973297
Allergy. 2000 Jan;55(1):69-73
pubmed: 10696859

Auteurs

Tobias Ankermann (T)

Childrens Hospital, Städtisches Krankenhaus Kiel gGmbH, Kiel, and.

Randolf Brehler (R)

Childrens Hospital, Städtisches Krankenhaus Kiel gGmbH, Kiel, and.
Department of Dermatology, University Hospital Münster, Germany.

Classifications MeSH